NCT03051620View on ClinicalTrials.gov

Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Osteoporosis
Interventions
DRUG

Discontinue alendronate

136 patients with osteoporosis stopping treatment with alendronate.

Trial Locations (1)

8000

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Aarhus University Hospital

OTHER

NCT03051620 - Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate | Biotech Hunter | Biotech Hunter